Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer (NYESO SCT)
Investigator(s):
Theodore Nowicki, MD;
Organization:
UCLA
NCT Number:
Disease Name:
Sarcoma
Disease Category:
Trial Phases:
Phase 1
Trial Status:
Recruiting
Trial Contact:
Theodore Scott Nowicki, MD, PhD
310-206-2090
Antonio Ribas, MD
310-206-3928